The US Food and Drug Administration has for the first time approved a video game for treating attention deficit hyperactivity disorder in children.
The FDA said on Monday the game built by Boston-based Akili Interactive Labs can improve attention function. The game, called EndeavorRx, requires a prescription and is designed for children ages 8 to 12 with certain symptoms of ADHD.
It’s the first time the FDA has cleared a digital therapy for improving ADHD symptoms, and the first time the agency has ever authorised marketing of a game-based therapy for any condition.
Also read: Trends Pharma launches disinfectant tablet
The FDA says it looked at data from multiple studies in more than 600 children. A video of the game shows a character travelling a racecourse-like path in a hover board. Sensory and motor tasks are designed to help the player improve cognitive functioning.
“We’re proud to make history today with FDA’s decision,” Akili CEO Eddie Martucci said in a statement. “We’re using technology to help treat a condition in an entirely new way as we directly target neurological function through medicine that feels like entertainment.”